T. Rowe Price Associates
ZTS icon

T. Rowe Price Associates’s Zoetis ZTS Stock Holding History

T. Rowe Price Associates’s Portfolio ZTS Stock Details ZTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120M Sell
1,018,088
-273,827
-21% -$33.9M 0.01% 578
2025
Q4 		$163M Buy
1,291,915
+252,725
+24% +$33M 0.02% 523
2025
Q3 		$152M Buy
1,039,190
+64,019
+7% +$9.68M 0.02% 519
2025
Q2 		$152M Sell
975,171
-489,645
-33% -$77.6M 0.02% 492
2025
Q1 		$241M Sell
1,464,816
-371,537
-20% -$61.8M 0.03% 384
2024
Q4 		$299M Sell
1,836,353
-2,289,668
-55% -$409M 0.03% 352
2024
Q3 		$806M Sell
4,126,021
-667,904
-14% -$123M 0.09% 200
2024
Q2 		$831M Sell
4,793,925
-4,578,179
-49% -$762M 0.1% 181
2024
Q1 		$1.59B Sell
9,372,104
-4,344,577
-32% -$814M 0.19% 109
2023
Q4 		$2.71B Buy
13,716,681
+3,244,074
+31% +$574M 0.36% 50
2023
Q3 		$1.82B Buy
10,472,607
+1,651,255
+19% +$300M 0.27% 75
2023
Q2 		$1.52B Sell
8,821,352
-1,454,141
-14% -$251M 0.21% 91
2023
Q1 		$1.71B Buy
10,275,493
+2,204,517
+27% +$361M 0.26% 80
2022
Q4 		$1.18B Sell
8,070,976
-2,335,030
-22% -$346M 0.19% 118
2022
Q3 		$1.55B Buy
10,406,006
+395,882
+4% +$66.2M 0.25% 74
2022
Q2 		$1.72B Buy
10,010,124
+504,073
+5% +$87.2M 0.22% 95
2022
Q1 		$1.79B Buy
9,506,051
+696,998
+8% +$138M 0.18% 115
2021
Q4 		$2.15B Sell
8,809,053
-786,747
-8% -$172M 0.19% 111
2021
Q3 		$1.86B Sell
9,595,800
-559,100
-6% -$113M 0.18% 119
2021
Q2 		$1.89B Buy
10,154,900
+92,590
+0.9% +$16.1M 0.18% 125
2021
Q1 		$1.58B Buy
10,062,310
+912,551
+10% +$145M 0.16% 142
2020
Q4 		$1.51B Buy
9,149,759
+29,465
+0.3% +$4.79M 0.16% 143
2020
Q3 		$1.51B Buy
9,120,294
+875,491
+11% +$135M 0.17% 122
2020
Q2 		$1.13B Sell
8,244,803
-4,327
-0.1% -$565K 0.14% 152
2020
Q1 		$971M Buy
8,249,130
+3,178,866
+63% +$419M 0.15% 144
2019
Q4 		$671M Buy
5,070,264
+965,008
+24% +$120M 0.09% 251
2019
Q3 		$511M Buy
4,105,256
+1,311,947
+47% +$158M 0.07% 274
2019
Q2 		$317M Sell
2,793,309
-524,592
-16% -$54.9M 0.04% 365
2019
Q1 		$334M Buy
3,317,901
+414,224
+14% +$37.6M 0.05% 335
2018
Q4 		$248M Sell
2,903,677
-835,141
-22% -$75.2M 0.04% 378
2018
Q3 		$342M Sell
3,738,818
-1,377,590
-27% -$122M 0.05% 361
2018
Q2 		$436M Sell
5,116,408
-4,832,383
-49% -$408M 0.07% 285
2018
Q1 		$831M Sell
9,948,791
-12,971,998
-57% -$1.02B 0.13% 177
2017
Q4 		$1.65B Sell
22,920,789
-6,322,506
-22% -$434M 0.27% 85
2017
Q3 		$1.86B Sell
29,243,295
-5,737,646
-16% -$359M 0.32% 74
2017
Q2 		$2.18B Sell
34,980,941
-5,210,666
-13% -$308M 0.39% 54
2017
Q1 		$2.15B Sell
40,191,607
-1,046,299
-3% -$56.5M 0.4% 53
2016
Q4 		$2.21B Buy
41,237,906
+6,374,524
+18% +$324M 0.44% 50
2016
Q3 		$1.81B Buy
34,863,382
+3,806,515
+12% +$193M 0.36% 64
2016
Q2 		$1.47B Buy
31,056,867
+10,688,777
+52% +$505M 0.31% 68
2016
Q1 		$903M Buy
20,368,090
+4,599,247
+29% +$195M 0.19% 131
2015
Q4 		$756M Buy
15,768,843
+2,829,469
+22% +$128M 0.16% 151
2015
Q3 		$533M Sell
12,939,374
-748,052
-5% -$34.7M 0.12% 196
2015
Q2 		$660M Sell
13,687,426
-2,662,984
-16% -$127M 0.14% 171
2015
Q1 		$757M Sell
16,350,410
-1,071,544
-6% -$48.3M 0.16% 159
2014
Q4 		$750M Sell
17,421,954
-5,508,369
-24% -$224M 0.16% 165
2014
Q3 		$847M Buy
22,930,323
+2,888,749
+14% +$98.9M 0.19% 140
2014
Q2 		$647M Buy
20,041,574
+6,953,363
+53% +$213M 0.14% 179
2014
Q1 		$379M Buy
13,088,211
+6,519,605
+99% +$199M 0.09% 274
2013
Q4 		$215M Buy
6,568,606
+163,200
+3% +$5.21M 0.05% 418
2013
Q3 		$199M Buy
6,405,406
+3,452,513
+117% +$106M 0.05% 401
2013
Q2 		$91.2M Buy
+2,952,893
New +$95.6M 0.02% 601

Other funds holding ZTS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates's ZTS Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Zoetis (ZTS) stake by 21% in Q1 2026, selling an estimated $33.9M and leaving 1,018,088 shares worth $120M. The position accounts for 0.01% of the portfolio, ranked #578.

T. Rowe Price Associates first reported a position in ZTS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.71B in Q4 2023. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • T. Rowe Price Associates held 1,018,088 shares of Zoetis worth $120M as of Q1 2026.
  • T. Rowe Price Associates sold 273,827 Zoetis shares in Q1 2026, an estimated $33.9M.
  • Zoetis made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #578 holding.
  • T. Rowe Price Associates first reported a position in Zoetis in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Zoetis position peaked at $2.71B in Q4 2023.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.